EUVIMEDEUVIMED entdecken
Open Access

Diagnostic yield of genome sequencing in children with progressive movement disorders

Luca Schierbaum, Enrique Gonzalez Saez-Diez, Amy Tam, Joshua Rong, Umar Zubair, Katerina Bernardi, Kathryn Yang, Vicente Quiroz, Zainab Zaman, Afshin Saffari, Siofra Carty, Habibah A P Agianda und 8 weitere

Brain · 2026

DOI: 10.1093/brain/awag050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2026. Verfasst von Luca Schierbaum und 19 weiteren Autor:innen. Beteiligte Einrichtung: Movement Disorders Program, Department of Neurology and F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, M…. Hauptthemen laut MEDLINE: Movement Disorders, Whole Genome Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, New England Epilepsy Foundation, Spastic Paraplegia Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Childhood-onset movement disorders are clinically and genetically heterogeneous, with over 500 implicated genes. Standard clinical genetic testing, including exome sequencing, has limited sensitivity for certain variants, including repeat expansions, structural variants, copy number variants and deep intronic changes. We evaluated the diagnostic utility of short-read whole-genome sequencing (srWGS) and, in selected cases, long-read whole-genome sequencing (lrWGS) in a real-world cohort of children and young adults with early-onset progressive movement disorders and prior non-diagnostic genetic testing. One hundred individuals (<30 years) with progressive movement disorders with a suspected genetic aetiology were recruited from a tertiary paediatric movement disorders programme. All had prior non-diagnostic testing. SrWGS was used to assess single nucleotide, copy number and structural variants, as well as repeat expansions; lrWGS was applied to select unsolved trios. Variants were reviewed by a multidisciplinary team using standard variant interpretation guidelines and phenotype correlation. A molecular diagnosis was achieved in 27% (27/100) of cases, and candidate variants were identified in an additional 33% (33/100). Among solved cases, 81.5% (22/27) were identified from exome-level data, while 18.5% (5/27) required genome-level analysis to detect variants such as repeat expansions in HTT and FXN, an intragenic duplication in MECP2, an Alu insertion in ATM and a deletion in FA2H. Genome-level analysis contributed an additional diagnostic yield of only 5% (5/100). Notably, in 33.3% (9/27) of solved cases, variants had been reported previously but not recognized as diagnostic. LrWGS of 14 unsolved trios did not yield additional diagnoses. SrWGS provided a modest incremental yield over exome sequencing in early-onset movement disorders, with most diagnoses achieved through reanalysis of exome-level data. Findings highlight the importance of iterative variant interpretation and the need for improved analytic pipelines to fully realize the potential of genome sequencing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Movement DisordersWhole Genome SequencingHumansChildFemaleMaleAdolescentChild, PreschoolYoung AdultGenetic TestingAdultDNA Copy Number VariationsCohort StudiesShotgun Sequencing

Stichwörter der Autor:innen

childhood-onset movement disordersdiagnostic yielddystonialong-read sequencingspasticitywhole-genome sequencing

Autor:innen und Institutionen

  • Movement Disorders Program, Department of Neurology and F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02215 USA.
  • Medical Faculty, Heidelberg University, Heidelberg 69120, Germany.
  • Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Boston, MA 02115, USA.
  • Section of Pediatric Neurology and Developmental Neurosciences, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.

ORCID-Profile: Sanda Alexandrescu, Stephan Zuchner, Darius Ebrahimi-Fakhari

Förderung

  • NINDS NIH HHS
  • New England Epilepsy Foundation
  • Spastic Paraplegia Foundation
  • German Research Foundation
  • Deutsche Forschungsgemeinschaft
  • Lilly & Blair Foundation
  • International Parkinson and Movement Disorder Society
  • Boston Children's Hospital Translational Research

Zitieren

APA

Schierbaum, L., Gonzalez Saez-Diez, E., Tam, A., Rong, J., Zubair, U., Bernardi, K., Yang, K., Quiroz, V., Zaman, Z., Saffari, A., Carty, S., Agianda, H. A. P., Alexandrescu, S., Eichler, F., Sveden, A., Chopra, M., Calame, D. G., Danzi, M. C., Zuchner, S., & Ebrahimi-Fakhari, D. (2026). Diagnostic yield of genome sequencing in children with progressive movement disorders. Brain. https://doi.org/10.1093/brain/awag050

Vancouver

Schierbaum L, Gonzalez Saez-Diez E, Tam A, Rong J, Zubair U, Bernardi K, et al. Diagnostic yield of genome sequencing in children with progressive movement disorders. Brain. 2026. doi:10.1093/brain/awag050

BibTeX
@article{Schierbaum2026,
  author = {Schierbaum, Luca and Gonzalez Saez-Diez, Enrique and Tam, Amy and Rong, Joshua and Zubair, Umar and Bernardi, Katerina and Yang, Kathryn and Quiroz, Vicente and Zaman, Zainab and Saffari, Afshin and Carty, Siofra and Agianda, Habibah A P and Alexandrescu, Sanda and Eichler, Florian and Sveden, Abigail and Chopra, Maya and Calame, Daniel G and Danzi, Matt C and Zuchner, Stephan and Ebrahimi-Fakhari, Darius},
  title = {Diagnostic yield of genome sequencing in children with progressive movement disorders},
  journal = {Brain},
  year = {2026},
  doi = {10.1093/brain/awag050}
}
Kostenlos starten →